Precuneus activity during retrieval is positively associated with amyloid burden in cognitively normal older APOE4 carriers

Larissa Fischer,Eoin N Molloy,Alexa Pichet Binette,Niklas Vockert,Jonas Marquardt,Andrea Pacha Pilar,Michael C Kreissl,Jordana Remz,Judes Poirier,M Natasha Rajah,Sylvia Villeneuve,PREVENT-AD Research Group,Anne Maass

DOI: https://doi.org/10.1101/2024.07.18.604145

2024-07-22

Abstract:The precuneus is an early site of amyloid-beta accumulation. Previous cross-sectional studies reported increased precuneus fMRI activity in older adults with mild cognitive deficits or elevated amyloid-beta. However, longitudinal studies in early Alzheimer's disease (AD) risk stages are lacking and the interaction with Apolipoprotein-E (APOE) genotype is unclear. In the PREVENT-AD cohort, we assessed how precuneus activity during successful memory retrieval at baseline and over time relates to future amyloid-beta and tau burden and to change in memory performance. We further studied the moderation by APOE4 genotype. We included 165 older adults (age: 62.8 years; 113 female; 66 APOE4 carriers) who were cognitively normal at baseline and had a family history of AD. All participants performed task-fMRI at baseline and underwent [18F]-flortaucipir PET and [18F]-NAV4694 amyloid PET on average 5 years later. We found that higher baseline activity and greater longitudinal change in activity in precuneus were associated with higher subsequent amyloid-beta in APOE4 carriers but not non-carriers. There were no effects of precuneus activity on tau burden. Finally, APOE4 non-carriers with low baseline activity in the precuneus exhibited better longitudinal performance in an independent memory test compared to APOE4 non-carriers with high baseline activity and APOE4 carriers. Our findings suggest that higher task-related precuneus activity at baseline and over time are associated with subsequent amyloid-beta burden in cognitively normal APOE4 carriers. Our results further indicate that the absence of hyperactivation and the absence of the APOE4 allele is related with the best future cognitive outcome in cognitively normal older adults at risk for AD.

Neuroscience

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the relationship between functional magnetic resonance imaging (fMRI) activity in the precuneus during successful memory retrieval and future amyloid - beta (Aβ) and tau pathological burdens in cognitively normal elderly people, and to evaluate whether these relationships are modulated by the APOE4 genotype. Specifically, the researchers hope to answer the following questions:

1. **Are there differences in precuneus activity at baseline or over time between APOE4 carriers and non - carriers?**
2. **Is higher baseline precuneus activity and activity that increases over time related to future Aβ and tau pathological burdens?**
3. **Is higher activity or longitudinal changes in activity positively correlated (if beneficial) or negatively correlated (if harmful) with cognitive changes?**
4. **Does the APOE genotype modulate any associations between activity and pathology or cognition (for example, is higher activity only associated with more pathology in APOE4 carriers)?**

### Research Background

The precuneus is one of the regions affected early in Alzheimer's disease (AD), especially by the accumulation of amyloid - beta (Aβ). Previous studies have shown that fMRI activity in the precuneus increases in elderly people with mild cognitive impairment or elevated Aβ levels. However, there are fewer longitudinal studies in the early AD risk stage, and the influence of the APOE genotype (especially APOE4) on this relationship is unclear.

### Research Methods

The researchers used data from the PREVENT - AD cohort, which includes cognitively normal elderly people with a family history of AD. All participants underwent task - related fMRI scans at baseline and 18F - flortaucipir - PET and 18F - NAV4694 - Aβ - PET scans on average 5 years later. Using these data, the researchers evaluated the relationship between precuneus activity and future Aβ and tau pathological burdens and studied the modulatory role of the APOE4 genotype.

### Main Findings

1. **APOE4 carriers had higher baseline precuneus activity and increased activity more over time, which was associated with a higher subsequent Aβ burden.**
2. **Low baseline precuneus activity in non - APOE4 carriers was associated with better long - term memory performance.**
3. **The APOE4 genotype significantly influenced the relationship between precuneus activity and Aβ pathological burden, but no correlation with tau pathological burden was found.**

### Conclusion

This study provides new longitudinal evidence that hyperactivation in the posterior midline brain regions (such as the precuneus) is related to APOE4 - genotype - dependent early AD pathology. The results also suggest that the lack of hyperactivation and the presence of the APOE4 allele are associated with the best cognitive outcomes in the future for cognitively normal elderly people.